Last edition
News about "Glenmark"
Cosmo and Glenmark Receive UK MHRA Approval of Winlevi for Treatment of Acne
Winlevi® is a topical treatment for acne vulgaris in patients aged 12 years and older, marking a significant milestone in the commitment of both companies to providing innovative, patient-focused dermatology solutions.
Glenmark | 10/02/2025 | By Aishwarya
Glenmark Rolls Out Travoprost Ophthalmic Solution
Glenmark’s Travoprost Ophthalmic Solution USP, 0.004 percent is bioequivalent and therapeutically equivalent to the reference listed drug, Travatan Z Ophthalmic Solution USP, 0.004 percent of Sandoz, Inc.
Glenmark | 27/11/2024 | By Aishwarya
Glenmark Gets ANDA Approval for Esomeprazole Magnesium Delayed-Release Capsules
Glenmark has secured final approval by the United States Food & Drug Administration (US FDA) for Esomeprazole Magnesium Delayed-Release Capsules.
Glenmark | 15/06/2024 | By Aishwarya
Glenmark Signs Exclusive Marketing and Distribution Deal with BeiGene
Glenmark has signed an exclusive marketing and distribution agreement with BeiGene, a global oncology company.
Glenmark | 21/05/2024 | By Aishwarya | 266
Glenmark, Strides Pharma, Cipla recalls products in US
The products were recalled due to manufacturing issues
Glenmark | 22/08/2022 | By Sudeep Soparkar | 663
Pharma cos recall products in US due to manufacturing issues
Sun Pharma is recalling the affected lot due to "water leakage" leading to deviation from current good manufacturing practices (cGMP)
Glenmark | 25/07/2022 | By Sudeep Soparkar | 420
Glenmark | 28/06/2022 | By Sudeep Soparkar | 318
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy